丹麦双胎妊娠中主要先天性心脏病的患病率与产前检出率
丹麦全国注册研究纳入2009—2018年59例双胎妊娠、60例主要先天性心脏病,患病率4.6/1000双胎妊娠,单绒毛膜双胎高于双绒毛膜双胎;全国产前检出率68.3%,未检出者母亲BMI显著更高。
要点
- 双胎妊娠主要先天性心脏病患病率4.6/1000双胎妊娠,单绒毛膜双胎9.2/1000高于双绒毛膜双胎3.6/1000。
- 全国产前检出率68.3%,单心室心脏最高100%,主肺动脉窗、完全性肺静脉异位引流、Ebstein畸形、主动脉瓣狭窄和主动脉缩窄最低0-25%。
- 产前未检出主要先天性心脏病者母亲BMI中位数27 kg/m2,显著高于检出者的23 kg/m2(P=0.02)。
核心结论
- 双胎妊娠主要先天性心脏病患病率为4.6/1000妊娠,单绒毛膜双胎高于双绒毛膜双胎;产前检出率68.3%;产前未检出者母亲BMI更高。
研究设计与样本
- 全国注册研究,前瞻性收集10年数据,纳入2009—2018年丹麦胎儿医学数据库全部双胎妊娠中至少一胎产前和/或产后诊断主要先天性心脏病者,共59例双胎妊娠、60例病例,数据在覆盖全国的四个三级中心本地病历中产前和产后验证。
诊断标准与关键数值
- 主要先天性心脏病定义为生后第一年内需手术的先天性心脏病,排除室间隔缺损;患病率4.6/1000双胎妊娠(95%CI 3.5-6.0),1.9/1000活产(95%CI 1.3-2.5);双绒毛膜双胎3.6/1000双胎妊娠(95%CI 2.6-5.0),单绒毛膜双胎9.2/1000双胎妊娠(95%CI 5.8-13.7);全国产前检出率68.3%;单心室心脏检出率100%,主肺动脉窗、完全性肺静脉异位引流、Ebstein畸形、主动脉瓣狭窄和主动脉缩窄检出率0-25%。
临床应用与阅片要点
- 丹麦对双胎妊娠在常规早中孕期筛查外提供标准化筛查与监测方案:单绒毛膜双胎自孕15周起每2周一次,双绒毛膜双胎自孕18周起每4周一次。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the national prevalence and prenatal detection rate (DR) of major congenital heart disease (mCHD) in twin pregnancies without twin-to-twin transfusion syndrome (TTTS)-associated CHD in a Danish population following a standardized prenatal screening program.
METHODS: This was a national registry-based study of data collected prospectively over a 10-year period. In Denmark, all women with a twin pregnancy are offered standardized screening and surveillance programs in addition to first- and second-trimester screening for aneuploidies and malformation, respectively: monochorionic (MC) twins every 2 weeks from gestational week 15 and dichorionic (DC) twins every 4 weeks from week 18. The data were retrieved from the Danish Fetal Medicine Database and included all twin pregnancies from 2009-2018, in which at least one fetus had a pre- and/or postnatal mCHD diagnosis. mCHD was defined as CHD requiring surgery within the first year of life, excluding ventricular septal defects. All pregnancy data were pre- and postnatally validated in the local patient files at the four tertiary centers covering the entire country.
RESULTS: A total of 60 cases from 59 twin pregnancies were included. The prevalence of mCHD was 4.6 (95% CI, 3.5-6.0) per 1000 twin pregnancies (1.9 (95% CI, 1.3-2.5) per 1000 live births). The prevalences for DC and MC were 3.6 (95% CI, 2.6-5.0) and 9.2 (95% CI, 5.8-13.7) per 1000 twin pregnancies, respectively. The national prenatal DR of mCHD in twin pregnancies for the entire period was 68.3%. The highest DRs were in cases with univentricular hearts (100%) and the lowest with aortopulmonary window, total anomalous pulmonary venous return, Ebstein's anomaly, aortic valve stenosis and coarctation of the aorta (0-25%). Mothers of children with prenatally undetected mCHD had a significantly higher body mass index (BMI) compared to mothers of children with a prenatally detected mCHD (median, 27 kg/m2 and 23 kg/m2 , respectively; P = 0.02).
CONCLUSIONS: The prevalence of mCHD in twins was 4.6 per 1000 pregnancies and was higher in MC than DC pregnancies. The prenatal DR of mCHD in twin pregnancies was 68.3%. Maternal BMI was higher in cases of prenatally undetected mCHD. © 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Bouazzi M, Jørgensen DES, Andersen H, et al. Prevalence and detection rate of major congenital heart disease in twin pregnancies in Denmark. Ultrasound Obstet Gynecol. 2023. PMID: 37191390. doi:10.1002/uog.26249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。